Critical Survey: INLIF (NASDAQ:INLF) vs. Prestige Consumer Healthcare (NYSE:PBH)

INLIF (NASDAQ:INLF) and Prestige Consumer Healthcare (NYSE:PBH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Volatility & Risk

INLIF has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for INLIF and Prestige Consumer Healthcare, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INLIF	1	0	0	0	1.00
Prestige Consumer Healthcare	1	3	2	0	2.17

Prestige Consumer Healthcare has a consensus target price of $70.75, indicating a potential upside of 44.12%. Given Prestige Consumer Healthcare’s stronger consensus rating and higher possible upside, analysts clearly believe Prestige Consumer Healthcare is more favorable than INLIF.

Valuation & Earnings

This table compares INLIF and Prestige Consumer Healthcare”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INLIF	$18.41 million	3.01	-$5.45 million	N/A	N/A
Prestige Consumer Healthcare	$1.09 billion	2.14	$190.30 million	$3.91	12.55

Prestige Consumer Healthcare has higher revenue and earnings than INLIF.

Insider & Institutional Ownership

100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. 1.4% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares INLIF and Prestige Consumer Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
INLIF	N/A	N/A	N/A
Prestige Consumer Healthcare	17.48%	11.54%	6.16%

Summary

Prestige Consumer Healthcare beats INLIF on 10 of the 12 factors compared between the two stocks.

About INLIF

INLIF Ltd. is a holding company, which engages in the development of injection molding machine-dedicated manipulator arms. Its products include: Three-axis robot, Five-axis robot and bull head type manipulator. The company was founded on January 4, 2023 and is headquartered in Quanzhou, China.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.